Colgate-Palmolive reported Q2 revenue of $5.361 billion, up 4.9% year-over-year, according to an SEC Form 8-K filing.
📊 Price at time of writing (July 31, 2026, 21:08 KST)
$91.60 ▼ -2.02%
This Quarter at a Glance
Both revenue and adjusted earnings rose, but GAAP earnings per share — which includes one-time charges — actually declined. Gross margin (the share of revenue left after costs) improved, even as the company boosted advertising spend by 15% to fuel growth.
- Revenue: $5.361 billion, +4.9% year-over-year
- Adjusted EPS (Base Business): 99 cents, 4 cents above consensus estimates
- GAAP EPS: 86 cents, -5% year-over-year
- Operating income (GAAP): $1.016 billion, -6% year-over-year
- Gross margin: 61.5%, up 1.4 percentage points year-over-year
- First-half operating cash flow: $1.742 billion
Outlook
Colgate maintained its fiscal 2026 revenue growth outlook at 2-6%, unchanged from before. Organic revenue growth guidance (which reflects only pricing and volume gains) also remains at 1-4%. The company raised its gross margin outlook from 'declining' to 'flat,' and lifted its adjusted EPS growth forecast from low-single-digit to mid-single-digit. Noel Wallace, Colgate's Chairman and CEO, said, 'Volume growth has improved for three consecutive quarters despite a challenging operating environment.'
Market Reaction
Colgate's adjusted EPS beat consensus estimates by 4 cents. However, following the earnings release, Colgate shares fell 2.02% from the previous close to $91.60 as of 21:08 KST on July 31, 2026. International media noted that despite the earnings beat, the stock still declined.
Segment Breakdown
- North America: 17% of revenue, -3.0% YoY, operating income $192 million, +3%
- Latin America: 26% of revenue, +13.7% YoY, operating income $418 million, +14%
- Europe, Middle East & Africa: 21% of revenue, +3.5% YoY, operating income $263 million, +9%
- Asia Pacific: 14% of revenue, +4.9% YoY, operating income $209 million, +3%
- Hill's Pet Nutrition: 22% of revenue, +3.4% YoY, operating income $269 million, +2%
This article was automatically generated based on the original SEC Form 8-K filing and international media reports, with the goal of delivering key data promptly after the announcement. Readers are advised to review the company's official filing before making trading decisions. Stock prices reflect the time of writing and may differ from current levels.


